Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2017 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Prophylaxis and antibiotic therapy in management protocols of patients treated with oral and intravenous bisphosphonates.
Bermúdez-Bejarano EB, Serrera-Figallo MÁ, Gutiérrez-Corrales A, Romero-Ruiz MM, Castillo-de-Oyagüe R, Gutiérrez-Pérez JL, Torres-Lagares D. Bermúdez-Bejarano EB, et al. J Clin Exp Dent. 2017 Jan 1;9(1):e141-e149. doi: 10.4317/jced.53372. eCollection 2017 Jan. J Clin Exp Dent. 2017. PMID: 28149479 Free PMC article. Review.
OBJECTIVES: This article seeks to assess published evidence in order to evaluate the different protocols used for antibiotic prophylaxis and/or antibiotic therapy in the general context of patients treated with bisphosphonates
OBJECTIVES: This article seeks to assess published evidence in order to evaluate the different protocols used for antibiotic
Bisphosphonate induced osteochemonecrosis of the jaws: an ounce of prevention may be worth a pound of cure.
Hellstein JW, Marek CL. Hellstein JW, et al. Spec Care Dentist. 2006 Jan-Feb;26(1):8-12. doi: 10.1111/j.1754-4505.2006.tb01503.x. Spec Care Dentist. 2006. PMID: 16703928
Patient exposure to bisphosphonate drugs for the management of hypercalcemia of malignancy, osteolytic lesions of metastatic cancer and osteoporosis has led to increasing reports of osteochemonecrosis of the jaws (bis-phossy jaw). This serious and debilitatin
Patient exposure to bisphosphonate drugs for the management of hypercalcemia of malignancy, osteolytic lesions of metas